Heartmate 3型左心室辅助装置停用阿司匹林 - Suppr

Discontinuation of Aspirin in Heartmate 3 Left Ventricular Assist Device.

作者信息

Lim Hoong Sern, Ranasinghe Aaron, Mascaro Jorge, Howell Neil

机构信息

From the University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

出版信息

ASAIO J. 2019 Aug;65(6):631-633. doi: 10.1097/MAT.0000000000000859.

DOI:10.1097/MAT.0000000000000859

PMID:30074966

Abstract

摘要

相似文献

Discontinuation of Aspirin in Heartmate 3 Left Ventricular Assist Device.

ASAIO J. 2019 Aug;65(6):631-633. doi: 10.1097/MAT.0000000000000859.

Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.

J Thorac Cardiovasc Surg. 2008 Nov;136(5):1318-23. doi: 10.1016/j.jtcvs.2007.12.077. Epub 2008 Sep 14.

Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.

Ann Thorac Surg. 2008 Sep;86(3):832-40; discussion 832-40. doi: 10.1016/j.athoracsur.2008.05.016.

In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices.

J Thorac Cardiovasc Surg. 2019 Feb;157(2):591-599.e4. doi: 10.1016/j.jtcvs.2018.07.085. Epub 2018 Aug 6.

Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study.

J Thorac Cardiovasc Surg. 2000 Mar;119(3):581-7. doi: 10.1016/s0022-5223(00)70140-1.

Transition from cardiopulmonary bypass to the HeartMate left ventricular assist device.

Ann Thorac Surg. 1998 Mar;65(3):643-6. doi: 10.1016/s0003-4975(97)01353-2.

Electrical storm in the early phase of HeartMate II device implantation: Incidence, risk factors and prognosis.

Arch Cardiovasc Dis. 2018 May;111(5):332-339. doi: 10.1016/j.acvd.2017.07.006. Epub 2017 Dec 6.

Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device.

Eur J Cardiothorac Surg. 2009 Jun;35(6):1091-3. doi: 10.1016/j.ejcts.2009.01.042. Epub 2009 Mar 20.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.

Ann Thorac Surg. 2004 Apr;77(4):1321-7. doi: 10.1016/j.athoracsur.2003.09.089.

引用本文的文献

Antithrombotic therapy for durable left ventricular assist devices: protocol for a living systematic review with indirect comparison/network meta-analysis.

BMJ Open. 2024 Jun 25;14(6):e080110. doi: 10.1136/bmjopen-2023-080110.

Long-Term Withdrawal of Anticoagulation and Antiplatelet Therapy in a HeartMate 3 Left Ventricular Assist Device.

Cureus. 2022 Sep 4;14(9):e28779. doi: 10.7759/cureus.28779. eCollection 2022 Sep.

Chugging to silent machines: development of mechanical cardiac support.

Indian J Thorac Cardiovasc Surg. 2020 Aug;36(Suppl 2):234-246. doi: 10.1007/s12055-020-01010-2. Epub 2020 Aug 25.

Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study.

J Heart Lung Transplant. 2020 Jun;39(6):518-525. doi: 10.1016/j.healun.2020.03.001. Epub 2020 Mar 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Discontinuation of Aspirin in Heartmate 3 Left Ventricular Assist Device.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献